The China Clinical Trials Outsourcing Congress 2013

The 6th China Clinical Trials Outsourcing Congress will address the operational, logistical and regulatory challenges of conducting clinical trials in China as well developing post approval markets within China.

Some of the topics under discussion will be –

-Is there still a gap between the international and Chinese standards for conducting clinical trials?
-What are the new opportunities / areas for clinical trials in China?
-Getting approval for a clinical trial application is a time-consuming process in China. -How does this affect the market and the players and what can be done to minimise this?
-Do foreign CROs have an edge over local companies in China?
-Conducting oncology clinical trials in China
-Utilizing unique gene pools found in China to conduct pharmacogenomic studies
-Understanding the challenges of site selection in China and how this will affect the outcome of clinical trials
-The challenges and benefits of conducting clinical trials in tier 2 and 3 cities in China
-How language and cultural barriers can be overcome
-Patient recruitment challenges in China – a large treatment naïve population does not necessarily mean recruitment will be easier
-Overcoming logistical barriers to conducting clinical trials in China – setting up the perfect supply chain
-Requirements and considerations for commercialisation after successful trial completion